Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian J North

Showing results (41-50 of 59) with videos related to

Pageof 6
Sort By:
Nature Communications|November 19, 2021
Genetic fusions favor tumorigenesis through degron loss in oncogenesJing Liu, Collin Tokheim, Jonathan D Lee, et al.
Nature Communications|July 31, 2025
Author Correction: Genetic fusions favor tumorigenesis through degron loss in oncogenesJing Liu, Collin Tokheim, Jonathan D Lee, et al.
Biochimica Et Biophysica Acta. Reviews on Cancer|August 27, 2019
Functional analysis of deubiquitylating enzymes in tumorigenesis and developmentJi Cheng, Jianping Guo, Brian J North, et al.
The American Journal of Pathology|July 28, 2004
Expression of histone deacetylase 8, a class I histone deacetylase, is restricted to cells showing smooth muscle differentiation in normal human tissuesDavid Waltregny, Laurence De Leval, Wendy Glénisson, et al.
Protein & Cell|March 3, 2018
SCF<sup>β-TRCP</sup> E3 ubiquitin ligase targets the tumor suppressor ZNRF3 for ubiquitination and degradationYanpeng Ci, Xiaoning Li, Maorong Chen, et al.
Cell Reports|November 10, 2021
Interplay between protein acetylation and ubiquitination controls MCL1 protein stabilityKouhei Shimizu, Min Gi, Shugo Suzuki, et al.
Journal of the American Heart Association|March 7, 2025
BubR1 Controls Heart Development by Promoting Expression of Cardiogenesis RegulatorsRenju Pun, Aradhana Thapa, Sylar R Takafuji, et al.
Developmental Biology|September 10, 2002
N-twist, an evolutionarily conserved bHLH protein expressed in the developing CNS, functions as a transcriptional inhibitorMichael P Verzi, Joshua P Anderson, Evdokia Dodou, et al.
Neoplasia (New York, N.Y.)|September 29, 2012
Inhibition of SIRT2 potentiates the anti-motility activity of taxanes: implications for antineoplastic combination therapiesKatiuscia Bonezzi, Dorina Belotti, Brian J North, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 28, 2011
Sir-two-homolog 2 (Sirt2) modulates peripheral myelination through polarity protein Par-3/atypical protein kinase C (aPKC) signalingBogdan Beirowski, Jason Gustin, Sean M Armour, et al.
Pageof 6

Showing results (41-50 of 59) with videos related to

Sort By:
Pageof 6
Nature Communications|November 19, 2021
Genetic fusions favor tumorigenesis through degron loss in oncogenesJing Liu, Collin Tokheim, Jonathan D Lee, et al.
Nature Communications|July 31, 2025
Author Correction: Genetic fusions favor tumorigenesis through degron loss in oncogenesJing Liu, Collin Tokheim, Jonathan D Lee, et al.
Biochimica Et Biophysica Acta. Reviews on Cancer|August 27, 2019
Functional analysis of deubiquitylating enzymes in tumorigenesis and developmentJi Cheng, Jianping Guo, Brian J North, et al.
The American Journal of Pathology|July 28, 2004
Expression of histone deacetylase 8, a class I histone deacetylase, is restricted to cells showing smooth muscle differentiation in normal human tissuesDavid Waltregny, Laurence De Leval, Wendy Glénisson, et al.
Protein & Cell|March 3, 2018
SCF<sup>β-TRCP</sup> E3 ubiquitin ligase targets the tumor suppressor ZNRF3 for ubiquitination and degradationYanpeng Ci, Xiaoning Li, Maorong Chen, et al.
Cell Reports|November 10, 2021
Interplay between protein acetylation and ubiquitination controls MCL1 protein stabilityKouhei Shimizu, Min Gi, Shugo Suzuki, et al.
Journal of the American Heart Association|March 7, 2025
BubR1 Controls Heart Development by Promoting Expression of Cardiogenesis RegulatorsRenju Pun, Aradhana Thapa, Sylar R Takafuji, et al.
Developmental Biology|September 10, 2002
N-twist, an evolutionarily conserved bHLH protein expressed in the developing CNS, functions as a transcriptional inhibitorMichael P Verzi, Joshua P Anderson, Evdokia Dodou, et al.
Neoplasia (New York, N.Y.)|September 29, 2012
Inhibition of SIRT2 potentiates the anti-motility activity of taxanes: implications for antineoplastic combination therapiesKatiuscia Bonezzi, Dorina Belotti, Brian J North, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 28, 2011
Sir-two-homolog 2 (Sirt2) modulates peripheral myelination through polarity protein Par-3/atypical protein kinase C (aPKC) signalingBogdan Beirowski, Jason Gustin, Sean M Armour, et al.
Pageof 6